Nutriband coo alan smith ph.d. selected for fda center for research on complex generics stakeholder expert committee

Orlando, fl / accesswire / march 2, 2023 / nutriband inc. (the "company") (nasdaq:ntrb)(nasdaq:ntrbw) today announced that alan smith, ph.d., chief operating officer (coo), nutriband, and president of its subsidiary, 4p therapeutics llc ("4p therapeutics"), has been selected for the fda's center for research on complex generics stakeholder expert committee on adhesion testing for transdermal/topical delivery systems.
NTRB Ratings Summary
NTRB Quant Ranking